Skip to main content

Table 3 Investigations ordered in the ED

From: The clinical presentation, utilization, and outcome of individuals with sickle cell anaemia presenting to urban emergency department of a tertiary hospital in Tanzania

 

Overall

Died

Survived

Relative risk

P-value

n/N (%)

n/N (%)

n/N (%)

RR (95%CI)

Laboratory Tests

 WBC Ω (> 11 K/uL)

346/656 (52.7)

11/16 (68.8)

335/640 (52.3)

2.0 (0.7–5.6)

0.2

 Haemoglobin (< 7 g/dL)

342/656 (52.1)

16/16 (100)

326/640 (50.9)

30.3 (1.8–503)

0.02

 Abnormal urine results δ

11/63 (17.5)

1/16 (6.3)

10/47 (21.3)

0.3 (0.04–2.11)

0.2

 Malaria test positive

48/415 (11.6)

12/16 (75)

36/399 (9.0)

22.9 (7.7–68)

< 0.0001

 Elevated RFTβ

24/219 (11.0)

9/16 (56.3)

15/203 (7.4)

10.4 (4.2–25.5)

< 0.0001

 Low RBGη (< 3 mmol/L)

39/627 (6.2)

12/16 (75)

27/611 (4.4)

45.2 (15.3–133.8)

< 0.0001

Imaging Tests

 Abnormal chest x-ray α

30/85 (35.3)

11/16 (68.8)

19/69 (27.5)

4.0 (1.5–10.5)

0.004

 Abnormal brain CT scan ρ

7/26 (26.9)

5/16 (31.3)

2/10 (20)

1.2 (0.67–2.2)

0.5

  1. Ω WBC-White Blood Cell
  2. δ Presence of blood in urine, leukocytes, nitrites, albumin, or glucose
  3. α Signs of infection or stroke
  4. β RFT-Renal function test
  5. η RBG-Random Blood Glucose
  6. α Pneumonic changes
  7. ρ Signs of stroke